Maygriss Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-01-2025
- Paid Up Capital ₹ 0.50 M
as on 04-01-2025
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 M
as on 04-01-2025
- Revenue -40.79%
(FY 2020)
- Profit -105.11%
(FY 2020)
- Ebitda 61.08%
(FY 2020)
- Net Worth -7.41%
(FY 2020)
- Total Assets -15.96%
(FY 2020)
About Maygriss Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.20 M.
Sumit Gupta and Deepak Singla serve as directors at the Company.
- CIN/LLPIN
U74999PB2017PTC046931
- Company No.
046931
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Patiala, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maygriss Healthcare Private Limited offer?
Maygriss Healthcare Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Digestive System Drugs & Medicines, Antiemetic, Laxatives, Dietary Supplements, Common Disease Medicines, Pharmaceutical Tablets.
Who are the key members and board of directors at Maygriss Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Gupta  | Director | 05-Sep-2017 | Current |
| Deepak Singla | Director | 05-Sep-2017 | Current |
Financial Performance of Maygriss Healthcare.
Maygriss Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 40.79% decrease. The company also saw a substantial fall in profitability, with a 105.11% decrease in profit. The company's net worth dipped by a decrease of 7.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maygriss Healthcare?
In 2020, Maygriss Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2020 | Others | ₹0.20 M | Open |
| 25 Oct 2018 | Others | ₹1.00 M | Open |
How Many Employees Work at Maygriss Healthcare?
Unlock and access historical data on people associated with Maygriss Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maygriss Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maygriss Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.